Monitor post-trial motions and any appeal by Lilly. A final judgment without appeal could provide a significant cash infusion for Nektar, while an appeal would extend uncertainty.
Price Chart
Executive Summary
Nektar Therapeutics won a $90 million jury verdict against Eli Lilly for breach of the implied covenant of good faith and fair dealing in their license agreement for rezpegaldesleukin. The verdict is subject to post-trial motions and potential appeals, so the cash inflow is not yet certain.
Key Facts
- Jury awarded Nektar $90 million in damages plus interest to be determined by the court.
- Verdict found Lilly breached the implied covenant of good faith and fair dealing in the License Agreement.
- The verdict remains subject to post-trial proceedings and any resulting judgment may be appealed.
- Trial began September 8, 2026; verdict returned September 24, 2026.
Financial Impact
$90 million jury award plus undetermined interest; material relative to Nektar's market cap.
Risk Factors
- Post-trial motions could reduce or overturn the verdict.
- Lilly may appeal, delaying any payment by years.
- The $90 million award may not be collectible if appealed or reduced.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-103215 |
| Document: 0001213900-26-103215-index-headers.html | 0001213900-26-103215 |
| Document: 0001213900-26-103215-index.html | 0001213900-26-103215 |
| Document: 0001213900-26-103215.txt | 0001213900-26-103215 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 26d ago | 8-K | $46.99 $43.58 | ▼ −7.26% | ▼ −8.00% | $37.97 (−19.20%) |
Sep 28, 2026 29d ago | SC 13G/A | $60.40 $59.24 | ▼ −1.92% | ▼ −1.74% | $37.97 (−37.14%) |
Sep 25, 2026 4w ago | 8-K | $57.06 $60.40 | ▲ +5.85% | ▲ +6.60% | $37.97 (−33.46%) |
Aug 13, 2026 10w ago | Press Release | $73.02 $72.67 | ▼ −0.48% | ▼ −0.01% | $37.97 (−48.00%) |
Aug 9, 2026 11w ago | Institutional Cluster | $74.86 $75.50 | ▲ +0.85% | ▲ +1.17% | $37.97 (−49.28%) |
Aug 7, 2026 11w ago | Court Ruling | $74.86 $75.50 | ▲ +0.85% | ▲ +1.17% | $37.97 (−49.28%) |
Jul 28, 2026 12w ago | Press Release | $70.68 $71.45 | ▲ +1.09% | ▼ −0.59% | $37.97 (−46.28%) |
Jun 11, 2026 19w ago | Institutional Cluster | $59.21 $59.38 | ▲ +0.29% | ▼ −0.25% | $37.97 (−35.87%) |
Jun 11, 2026 19w ago | Institutional Cluster | $59.21 $59.38 | ▲ +0.29% | ▼ −0.25% | $37.97 (−35.87%) |
May 21, 2026 22w ago | Insider Cluster | $66.61 $65.56 | ▲ +1.58% | ▲ +2.16% | $37.97 (+43.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers